PMV Pharmaceuticals Future Growth
Future criteria checks 0/6
PMV Pharmaceuticals is forecast to grow earnings and revenue by 5.8% and 67.1% per annum respectively while EPS is expected to grow by 14.6% per annum.
Key information
5.8%
Earnings growth rate
14.6%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | 67.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Apr 2024 |
Recent future growth updates
Recent updates
Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth
Apr 20Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth
Dec 22We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth
Sep 08Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation
May 10PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans
Jan 11Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth
Sep 22PMV Pharmaceuticals GAAP EPS of -$0.38 beats by $0.04
Aug 09PMV Pharma joins Merck to study lead candidate with Keytruda
Jul 18Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth
Jun 09Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation
Feb 23Companies Like PMV Pharmaceuticals (NASDAQ:PMVP) Are In A Position To Invest In Growth
Nov 05Here's Why We're Not Too Worried About PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Situation
Jul 23PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Strong Position To Grow Its Business
Apr 09Do Institutions Own PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares?
Dec 25PMV Pharmaceuticals reports Q3 results
Nov 13Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 3 | -78 | -95 | -70 | 4 |
12/31/2025 | N/A | -81 | -68 | -62 | 5 |
12/31/2024 | N/A | -73 | -64 | -57 | 5 |
12/31/2023 | N/A | -69 | -57 | -56 | N/A |
9/30/2023 | N/A | -73 | -61 | -59 | N/A |
6/30/2023 | N/A | -74 | -64 | -60 | N/A |
3/31/2023 | N/A | -74 | -68 | -61 | N/A |
12/31/2022 | N/A | -73 | -72 | -64 | N/A |
9/30/2022 | N/A | -72 | -67 | -60 | N/A |
6/30/2022 | N/A | -69 | -61 | -56 | N/A |
3/31/2022 | N/A | -65 | -54 | -52 | N/A |
12/31/2021 | N/A | -58 | -48 | -47 | N/A |
9/30/2021 | N/A | -50 | -46 | -45 | N/A |
6/30/2021 | N/A | -44 | -41 | -40 | N/A |
3/31/2021 | N/A | -39 | -38 | -38 | N/A |
12/31/2020 | N/A | -34 | -33 | -33 | N/A |
9/30/2020 | N/A | -31 | -28 | -28 | N/A |
6/30/2020 | N/A | -28 | -26 | -26 | N/A |
3/31/2020 | N/A | -27 | -25 | -25 | N/A |
12/31/2019 | N/A | -25 | -22 | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PMVP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PMVP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PMVP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PMVP is forecast to have no revenue next year.
High Growth Revenue: PMVP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PMVP's Return on Equity is forecast to be high in 3 years time